Aabo, Gitte (Leo Pharma 201511 CEO) |
Chief Executive Officer (CEO) |
Leo Pharma (Group) |
Denmark |
Aamund, Asger (Bavarian Nordic 200804 Chairman) |
n. a. |
Bavarian Nordic (Group) |
Denmark |
Aasen, Ove T. (DiaMan AS 201804 CEO) |
Chief Executive Officer (CEO) |
DiaMan AS |
Norway |
Aastrup, Teodor (Attana 200502) |
n. a. |
Attana (Group) |
Sweden |
Aastveit, Are (Norwegian University for Biosciences and the Environment 200601) |
n. a. |
Norwegian University of Life Sciences (UMB) |
Norway |
Abate, Emmanuel (Danaher 202210 President Genomic Medicine at Cytiva) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United Kingdom (GB) |
Abrams, Judith R. (Editas Medicine 201910– CMO before EMD Serono RnD Institute + CorMedix + Celgene + Novo Nordisk) |
Chief Medical Officer (CMO) |
Editas Medicine Inc. (Nasdaq: EDIT) |
United States (USA) |
Absalonsen, Karin (Hannibal Innovation 202310) |
n. a. |
Hannibal Innovation ApS |
Denmark |
Acosta, Colleen (Freya Biosciences 20231212 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Freya Biosciences ApS |
Denmark |
Adams, Nicholas (Clavis Pharma 201107– CBO before Antisoma since 1999 BusDev Director + Manager + Ciba-Geiga + Eisai) |
Chief Business Officer (CBO) |
Aqualis ASA |
Norway |
Adlersson, Lars (Medivir 200609 CEO + President) |
Chief Executive Officer (CEO) |
Medivir (Group) |
Sweden |
af Winklerfelt, Michael (Oasmia 202008 CFO) |
Chief Financial Officer (CFO) |
Oasmia Pharmaceutical AB |
Sweden |
Agarwal, Shefali (Valerio Therapeutics 202404 CEO before Onxeo 202201 Board Chair) |
Chief Executive Officer (CEO) |
Valerio Therapeutics (Group) |
France |
Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) |
Managing Partner (investment firm) |
Lundbeck (Group) |
Denmark |
Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) |
Chief Executive Officer (CEO) |
Asahi Kasei (Group) |
Sweden |
Ahanola, Jani (Noona Healthcare 201611 CEO) |
Chief Executive Officer (CEO) |
Noona Healthcare (FI) |
Finland |
Ahlberg, Christer (Cinclus Pharma 202106– CEO before Sedana Medical Group) |
Chief Executive Officer (CEO) |
Cinclus Pharma (Group) |
Sweden |
Ahomäki, Satu (Orion Corp 202001 SVP Commercial Operations) |
Chief Commercial Officer (CCO) |
Orion Corporation (Group) |
Finland |
Aiolfi, Franco (Biohit 201304– CEO of Biohit Italy before EuroClone) |
Chief Executive Officer (CEO) |
Biohit (Group) |
Italy |
Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director) |
Managing Director |
Hadean Ventures AS |
Norway |
Alajmovic, Sana (Sigrid Therapeutics 201909 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sigrid Therapeutics AB |
Sweden |
Alamaa, Marie-Louise (PledPharma 202011 CFO) |
Chief Financial Officer (CFO) |
Egetis Therapeutics (Group) |
Sweden |
Albers, Jeffrey W. (Jeff) (Blueprint Medicinces 201201– President of Algeta US + Genzyme + Mintz Levin) |
Chief Executive Officer (CEO) |
Blueprint Medicines (Group) |
United States (USA) |
Albertella, Mark (Storm Therapeutics 201905– VP Translational Oncology before Medivir + Argenta + OSI Pharmaceuticals) |
Research & Development Manager |
Storm Therapeutics Ltd. |
United Kingdom (GB) |
Albinus, Bjørn (Cheminova 200504 Managing Director) |
Managing Director |
Auriga Industries (Group) |
Denmark |
Albisser, Zeno (Hemispherian 202105 CEO) |
Chief Executive Officer (CEO) |
Hemispherian AS |
Norway |
Albrecht, Claudio (Actavis 201201 CEO) |
Chief Executive Officer (CEO) |
Teva (Group) |
Iceland |
Albrecht, Uwe (Mediconomics 201704 Managing Director) |
Managing Director |
Mediconomics GmbH |
Germany |
Albrechtsen, Morten (Nanovi ApS 201311 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Nanovi A/S |
Denmark |
Alenfall, Jan (Follicum 201902 CEO) |
Chief Executive Officer (CEO) |
Follicum AB |
Sweden |
Alevizopoulos, Konstantinos (APIM Therapeutics 201210 CEO) |
Chief Executive Officer (CEO) |
APIM Therapeutics AS |
Norway |
Alfaiate, Maria (Lundbeck 202408– EVP Commercial + Corporate Strategy before Bayer + AstraZeneca + MSD/Merck) |
Business Development Manager / Strategy Manager |
Lundbeck (Group) |
Denmark |
Alfheim, Jan A. (Oncoinvent 202006 CEO) |
Chief Executive Officer (CEO) |
Oncoinvent AS |
Norway |
Allen, Allison (Biovian 202209– Business Development Manager based in US before Cellectis + Alcami + Thermo Fisher) |
Business Development Manager / Strategy Manager |
Biovian Oy |
Finland |
Alriksson, Maria (Abera Bioscience 202203 CEO) |
Chief Executive Officer (CEO) |
Abera Bioscience AB |
Sweden |
Alsbo, Carsten (Exiqon 200904 Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Denmark |
Álvarez-Martos, Isabel (Cellugy 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellugy (DK) |
Denmark |
Ameri, Jacqueline (Pancryos 202205 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Pancryos ApS |
Denmark |
Anand, Ravi (Newron Pharmaceuticals 201103 CMO) |
Chief Medical Officer (CMO) |
Newron (Group) |
Italy |
Andersen, Bente Korsgaard (The Protein Brewery 202209 Board Chair) |
Board member, non-executive |
The Protein Brewery B.V. (TPB) |
Netherlands |
Andersén, Hedvig (Sweden (govt) 201201 Life Science Investment Manager at Industrifonden) |
Investment Manager |
Sweden (govt) |
Sweden |
Andersen, Peder M. (Biosergen 202104 CEO) |
Chief Executive Officer (CEO) |
Biosergen AB |
Sweden |
Andersen, Peter Høngaard (Forbion 202207– Operating Partner before Lundbeck + Novo Nordisk et al) |
Partner (venture partner) |
Forbion (Group) |
Netherlands |
Andersen, Thomas (Nextera AS 201510 CEO) |
Chief Executive Officer (CEO) |
Nextera AS |
Norway |
Andersin, Kati (Biohit 200905 Product Group Manager) |
Product Manager (personnel) |
Biohit (Group) |
Finland |
Andersson, Ann-Sofie (Copenhagen (govt) 201701 Business Development Manager Life Sciences at Copenhagen Capacity) |
Business Development Manager / Strategy Manager |
Copenhagen (govt region) |
Denmark |
Andersson, Claus A. (Sunstone Capital 201511 Partner Life Sciences) |
Partner (venture partner) |
Sunstone Life Science (Group) |
Denmark |
Andersson, Poul (DTU 201404 CEO of Bioneer A/S) |
Chief Executive Officer (CEO) |
Technical University of Denmark (DTU) |
Denmark |
Andersson, Thomas (Lund Univ 201202 CEO of LU Bio) |
Chief Executive Officer (CEO) |
University of Lund (Lund University) |
Sweden |
Andréasson, Sven (Active Biotech 199901–200808 President + CEO) |
Chief Executive Officer (CEO) |
Active Biotech (Group) |
Sweden |
Andresen, Thomas Lars (T-Cypher Bio 202108– CEO before Torque Therapeutics + Monta Biosciences + Nanovi) |
Chief Executive Officer (CEO) |
T-Cypher Bio Ltd. |
United Kingdom (GB) |
Andreu, Fernando (2curex 202101– before Indivumed + Sysmex Inostics) |
Chief Executive Officer (CEO) |
2cureX (Group) |
Denmark |
Andrews, Ron A. (Ronnie) (Life Technologies 201202– President Medical Sciences before GE Healthcare + CEO of Clarient) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
Angelin, Bo (Karolinksa Univ Hospital –200707–) |
n. a. |
Karolinska Institutet |
Sweden |
Ankarberg, Mattias (Sigrid Therapeutics 202301 Board Chair formerly at H&M) |
Board member, non-executive |
Sigrid Therapeutics AB |
Sweden |
Anzenberger, Uwe (Link Medical 202104 General Manager at Link Medical Germany) |
General Manager (management) |
Link Medical (Group) |
Norway |
Apostolopoulos, Petros (Bico 202108– CEO of Dispendix before 15 years at Festo) |
Chief Executive Officer (CEO) |
Bico (Group) |
Germany |
Armento, Alex (MatTek 202103 CEO) |
Chief Executive Officer (CEO) |
Bico (Group) |
United States (USA) |
Armstrong, Frank M. (CuraGen 200603 CEO before Bioaccelerate before Provensis before Bayer before Zeneca) |
Chief Executive Officer (CEO) |
CuraGen (Group) |
United States (USA) |
Arnesen, Øyvind Kongstun (Ultimovacs AS 201808 CEO) |
Chief Executive Officer (CEO) |
Ultimovacs (Group) |
Norway |
Arnhög, Mats (Active Biotech 201706 Board Chairman) |
Board member, non-executive |
Active Biotech (Group) |
Sweden |
Arvidson, Göran (Hansa Medical 201501– CFO before Swedish Orphan Biovitrum + Procardia + Pharmacia) |
Chief Financial Officer (CFO) |
Hansa Medical AB |
Sweden |
Arvidsson, Lars-Erik (AstraZeneca 200608 VP RnD Lund) |
Research & Development Manager |
AstraZeneca (Group) |
Sweden |
Askeland, Georgina (Hadean Ventures 202407 Senior Associate) |
Associate (venture capital) |
Hadean Ventures AS |
Norway |
Asp, Mikael (Oasmia Pharmaceutical 201703 CEO) |
Chief Executive Officer (CEO) |
Oasmia Pharmaceutical AB |
Sweden |
Astrom, Kalle (Finnvera 201306 Investment Manager) |
Investment Manager |
Finland (govt) |
|
Atkins, David (Congenica 201801– CEO before Synevo + Leica Biosystems + JnJ/Ortho Clinical Diagnostics) |
Chief Executive Officer (CEO) |
Congenica (Group) |
United Kingdom (GB) |
Aubry, Xavier (Da Vinci Labs 2021– CEO + Founder) |
Chief Executive Officer (CEO) |
Da Vinci Labs SAS |
France |
Aulin, Christopher (Capitainer 202301 CEO) |
Chief Executive Officer (CEO) |
Capitainer AB |
Sweden |
Aune, Trond Erik Vee (Vectron Biosolutions 201202 CEO) |
Chief Executive Officer (CEO) |
Vectron Biosolutions AS |
Norway |
Auster, Martin (Ascendis Pharma 201406– CBO before United Therapeutics as VP Business Development) |
Chief Business Officer (CBO) |
Ascendis Pharma (Group) |
Denmark |
Avery, Paul (BioStrata 201404– Managing Director before Chempetitive UK + Alto Marketing) |
Public Relations Manager / Investor Relations Manager |
BioStrata Ltd. (Biostrata Marketing) |
United Kingdom (GB) |
Axelson, Dodi (Danaher 202210 Head of Communciations at Cytiva) |
Public Relations Manager / Investor Relations Manager |
Danaher (Group) |
United Kingdom (GB) |
Axelsson, Thomas (Vitrolife AB 201305 CEO) |
Chief Executive Officer (CEO) |
Vitrolife (Group) |
Sweden |
Azzam, Fouad (Life Sciences Partners 201509 Partner at US Office of LSP) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
United States (USA) |
Bach, Dani (+ND Capital 202105 Partner formerly Aravis + Index Ventures) |
Managing Partner (investment firm) |
+ND Capital (f.k.a. NanoDimension) |
Switzerland |
Bache, Nicolai (Evosep 201803 Head of Applications) |
Technical Manager |
Evosep ApS |
Denmark |
Badger, Stephen (Blue Scientific 2013 Founder before Bruker + Veeco) |
Company Founder |
Blue Scientific Ltd. |
United Kingdom (GB) |
Baier, Manfred (Roche –201112 RETIRES 12/11 as head of Roche Applied Science) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
Baiget, Ester (Novozymes 202212 CEO) |
Chief Executive Officer (CEO) |
Novozymes (Group) |
Denmark |
Baines, Julian (EKF Diagnostics 201111 CEO) |
Chief Executive Officer (CEO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
Baker, Melinda (Ascendis Pharma 202108– Senior Director Coroporate Communications before Zogenix) |
Public Relations Manager / Investor Relations Manager |
Ascendis Pharma (Group) |
Denmark |
Bakker, Jeroen (Novo Group 202010 at Novo Seeds) |
Investment Manager |
Novo Group (Group) |
Denmark |
Baldry, Lindsay (Ramarketing 201603– before Pharma Nord + Admiral PR + Scott Partnership) |
Public Relations Manager / Investor Relations Manager |
Ramarketing (Group) |
United Kingdom (GB) |
Balendran, Anu (Alligator Bioscience 201805– VP Business Development before AstraZeneca External Innovation Director) |
Business Development Manager / Strategy Manager |
Alligator Bioscience (Group) |
Sweden |
Bank, Patti (Westwicke Partners 201502– Managing Director before Discern Securities + Pacific Growth Equities/Westbush) |
Managing Director |
ICR (Group) |
United States (USA) |
Barner, Andreas (Boehringer) |
Board member |
Boehringer Ingelheim (Group) |
Germany |
Barnes, Duane (Swedish Orphan Biovitrum 202101– Head of North America before UCB Inc + Amgen + Prime Therapeutics) |
Regional manager |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
Bataller, Juan (Zeltia 201303 General Manager of Genomica AB) |
General Manager (management) |
PharmaMar (Group) |
Sweden |
Bates, Elena (Optimum Strategic Communications 202304) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
Bauer, Michael (EQT 202206 Partner + Global Co-Head of Healthcare Team) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Sweden |
Bauer, Michael Karl (Novo Group 202406 Partner at Novo Holdings Venture Investments) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
Baum, Charles M. (Mirati Therapeutics 201211– CEO before Pfizer + Schering-Plough) |
Chief Executive Officer (CEO) |
|
|
Baumgartner, Florian (Spatial Transcirptomics 201812 COO) |
Chief Operating Officer (COO) |
10x Genomics (Group) |
Sweden |
Bech Jensen, Ejner (Agrobiomics 202309 CEO before Novozymes 201112 VP RnD) |
Chief Executive Officer (CEO) |
Agrobiomics (DK) |
Denmark |
Been, Kees (Kynexis 202311– CEO formerly EnVivo 200506– CEO before Bionaut CEO + Biogen) |
Chief Executive Officer (CEO) |
Kynexis (Group) |
Netherlands |
Behar, Greg (Recipharm 202401– CEO before CEO of Nestlé Health Science before Novartis + Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
Recipharm (Group) |
Sweden |
Bejker, David (Affibody 201207 CEO before HealthCap) |
Chief Executive Officer (CEO) |
Affibody Medical AB |
Sweden |
Beller, Steve (Nexstim 201801– VP + Genearl Manager North America) |
Regional manager |
Nexstim (Group) |
United States (USA) |
Benatti, Luca (EryDel 201804 CEO before Newron CEO + Founder) |
Chief Executive Officer (CEO) |
EryDel S.p.A. |
Italy |